Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CA-102N by Holy Stone Healthcare for Metastatic Colorectal Cancer: Likelihood of Approval
CA-102N is under clinical development by Holy Stone Healthcare and currently in Phase I for Metastatic Colorectal Cancer. According to...